Tempus AI, Inc Class A Common Stock

Tempus AI, Inc Class A Common Stock

Yahoo Finance • 5 days ago

Tempus Announces Multi-Year Collaboration with Moderna and Merck

Collaboration to Support Potential Commercialization of Intismeran Autogene CHICAGO, October 07, 2026--(BUSINESS WIRE)--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization... Full story

Yahoo Finance • 11 days ago

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

Equity Insider News Commentary AUSTIN, Texas, Oct. 1, 2026 /PRNewswire/ -- Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth... Full story

Yahoo Finance • 14 days ago

Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike

Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of... Full story

Yahoo Finance • 18 days ago

TempraMed expands LATAM distribution deal and announces C$1M financing

[AGREEMENT CONCEPT] cnythzl/iStock via Getty Images TempraMed Technologies (TMPTF [https://seekingalpha.com/symbol/TMPTF]) announced an amendment to its exclusive distribution agreement [https://seekingalpha.com/pr/20662495-tempramed-expa... Full story

Yahoo Finance • 24 days ago

Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver

For Immediate Release Chicago, IL – September 18, 2026 – Today, Zacks Investment Ideas features NVIDIA NVDA, Advanced Micro Devices AMD, Tempus AI TEM, Moderna MRNA, Super Micro Computer SMCI and Aya Gold & Silver Inc (AYA). Will 2026 Do... Full story

Yahoo Finance • 25 days ago

Will 2026 Doom and Gloom Lead to Opportunity?

2026 Has Been Full of Uncertainty So far in 2026, Wall Street equity investors have navigated an extremely complex landscape marked by macroeconomic forces, geopolitical pressures, and sector-specific concerns. Inflation has remained stub... Full story

Yahoo Finance • 25 days ago

Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook

Quick Read TEM surged 30% this week after Morgan Stanley spotlighted reimbursement pricing that could add between $330M and $400M in combined annual revenue across xT and xF diagnostics. Lefkofsky says Tempus will exceed its 25% multiyear... Full story

Yahoo Finance • 27 days ago

Cathie Wood Makes Striking Switch Between AI Stock Giants

This article first appeared on GuruFocus. Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms (NASDAQ:META) while selling a nearly identical dol... Full story

Yahoo Finance • 28 days ago

Cathie Wood buys $27.9 million of surging megacap stock

Cathie Wood, head of Ark Investment Management, often buys her favorite tech stocks when she sees a new opportunity. That's what she did last week, pouring $27.9 million into Meta Platforms (META) as the company pushes deeper into AI. La... Full story

Yahoo Finance • 29 days ago

Goldman rebalances its long duration stock basket

[Interest rate percentage sign symbol finance investment graph chart] alexsl The Goldman Sachs equity team has rebalanced its Long Duration Basket amid rising interest rates. Equities usually struggle to digest sharp increases in interes... Full story

Yahoo Finance • last month

FDA names acting heads of drug and vaccine units to permanent roles

[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House advisor Heidi Overton as the agency's nex... Full story

Yahoo Finance • last month

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

CHICAGO, September 04, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday,... Full story

Yahoo Finance • last month

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery ma... Full story

Yahoo Finance • last month

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?

It has been about a month since the last earnings report for Inspire Medical Systems (INSP). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend c... Full story

Yahoo Finance • last month

Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls

Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled... Full story

Yahoo Finance • last month

Tempus AI upgraded at Piper Sandler on growth drivers

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Piper Sandler upgraded Tempus AI (TEM [https://seekingalpha.com/symbol/TEM]) to Overweight from Neutral and raised its price target to $76 from $56 per share on Tuesd... Full story

Yahoo Finance • last month

Robinhood upgraded, Uber initiated: Wall Street's top analyst calls

Robinhood upgraded, Uber initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled b... Full story

Yahoo Finance • last month

Cathie Wood Drops $124 Million on AI Stocks, Dumps AMD

This article first appeared on GuruFocus. Cathie Wood's Ark (ARK) Invest made a sharp semiconductor rotation last week, adding roughly $53 million of Nvidia (NASDAQ:NVDA) and $41 million of Broadcom (NASDAQ:AVGO) while selling about $95 m... Full story

Yahoo Finance • last month

Cathie Wood buys $53 million of popular semiconductor stock

Cathie Wood, chief of Ark Investment Management, often uses post-earnings swings to add to her favorite tech stocks. This week, she's buying more Nvidia, adding $53 million to her stake as the stock pulled back a day after surging on bett... Full story

Yahoo Finance • 2 months ago

Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?

Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck. The companies said their Phase 3 INTerpath-001 trial met its recurrence-free survival endpoint for the personalized cancer therapy intism... Full story